Venture Visionary Partners’s GSK GSK Stock Holding History

Venture Visionary Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Buy	5,084 +66	+1%	+$3.49K	0.01%	606
2026 Q1	$277K	Buy	+5,018	New	+$272K	0.01%	532
2025 Q4	–	Sell	-5,398	Closed	-$233K	–	676
2025 Q3	$233K	Buy	5,398 +79	+1%	+$3.09K	0.01%	558
2025 Q2	$204K	Sell	5,319 -284	-5%	-$10.9K	0.01%	567
2025 Q1	$217K	Buy	+5,603	New	+$205K	0.01%	522
2024 Q4	–	Sell	-5,880	Closed	-$240K	–	562
2024 Q3	$240K	Sell	5,880 -300	-5%	-$12.3K	0.01%	493
2024 Q2	$238K	Sell	6,180 -230	-4%	-$9.68K	0.01%	496
2024 Q1	$275K	Buy	6,410 +800	+14%	+$33K	0.01%	467
2023 Q4	$208K	Sell	5,610 -143	-2%	-$5.13K	0.01%	483
2023 Q3	$209K	Buy	+5,753	New	+$204K	0.01%	464
2022 Q3	–	Sell	-5,384	Closed	-$293K	–	903
2022 Q2	$293K	Sell	5,384 -518	-9%	-$28.6K	0.02%	384
2022 Q1	$321K	Buy	5,902 +492	+9%	+$26.7K	0.02%	396
2021 Q4	$324K	Sell	5,410 -200	-4%	-$10.4K	0.02%	394
2021 Q3	$267K	Sell	5,610 -48	-0.8%	-$2.41K	0.02%	423
2021 Q2	$281K	Sell	5,658 -3,211	-36%	-$154K	0.02%	402
2021 Q1	$395K	Buy	8,869 +1,037	+13%	+$47.1K	0.03%	331
2020 Q4	$360K	Buy	+7,832	New	+$360K	0.04%	285

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Venture Visionary Partners's GSK Position: Q2 2026 in Review

Venture Visionary Partners increased its GSK (GSK) stake by 1.3% in Q2 2026, buying an estimated $3.49K and bringing the position to 5,084 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #606.

Venture Visionary Partners first reported a position in GSK in Q4 2020 and has held it in 17 quarters since. The position peaked at $395K in Q1 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Venture Visionary Partners held 5,084 shares of GSK worth $267K as of Q2 2026.
Venture Visionary Partners bought 66 GSK shares in Q2 2026, an estimated $3.49K.
GSK made up 0.01% of Venture Visionary Partners's portfolio in Q2 2026, its #606 holding.
Venture Visionary Partners first reported a position in GSK in Q4 2020 and has held it in 17 quarters since.
Venture Visionary Partners's GSK position peaked at $395K in Q1 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.